# US 2010/0143242 A1 · Delivery system for therapy comprising hollow seeds, and the method of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0143242 A1
- Document ID: US20100143242A1
- Status: Published application
- Kind: A1
- Application number: 12/654,556
- Filed: 2009-12-23
- Published: 2010-06-10
- Earliest claimed: 1999-08-25
- Inventors: Anatoly Dritschilo; Mira Jung; Manny R. Subramanian
- Web page: https://patentgrep.com/patent/US20100143242A1

## CPC

- A61M 37/0069: {Devices for implanting pellets, e.g. markers or solid medicaments (for introducing of radioactive sources for interstitial radiation therapy, i.e. brachytherapy A61N5/1027)}
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

Hollow metal and polymeric containers (or seeds) are provided having a therapeutic agent encapsulated therein, e.g., a nucleic acid or cytokine, that diffuses out of the seeds via one or more holes disposed therein and is thereby delivered to target sites, e.g., tumor cells. These hollow seeds can be precisely delivered to garget cites, e.g., within a tumor, preferably by use of stereotactic guidance, ultrasound, CT or MRI.

## Claims

### Claim 1

(canceled)

### Claim 2 (depends on 18)

The method of claim 18, wherein said container has a tubular configuration that is open at one or both ends.

### Claim 3 (depends on 2)

The method of claim 2, wherein said container has a length ranging from 0.002 inch to 2 inches, a diameter ranging from 0.004 inch to 0.2 inch, a wall thickness ranging from 0.0005 inch to 0.5 inch, and having one or more holes having an average diameter ranging from 0.0001 to 0.1 inch in diameter.

### Claim 4 (depends on 18)

The method of claim 18, wherein said hollow container is constructed of a metal or metal alloy comprising at least one metal or metal alloy selected from the group consisting of platinum, stainless steel, titanium, silver, and gold.

### Claim 5

(canceled)

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8 (depends on 18)

The method of claim 18, wherein precise placement of said therapeutic agent encapsulating container to said target site is visually confirmed by a method selected from the group consisting of stereotactic-guidance, CT, ultrasound, and MRI.

### Claim 9 (depends on 18)

The method of claim 18, wherein said therapeutic agent encapsulating container are implanted at one or more sites in a tumor.

### Claim 10 (depends on 9)

The method of claim 9, which is used to treat prostate cancer, head and neck cancer, brain cancer, liver cancer, or pancreatic cancer.

### Claim 11 (depends on 18)

The method of claim 18, which is used to target a therapeutic agent to sites comprising cancerous lesions, infection or inflammation.

### Claim 12 (depends on 18)

The method of claim 18, wherein said hollow container contains within the hollow interior a nucleic acid sequence.

### Claim 13 (depends on 12)

The method of claim 12, wherein said nucleic acid sequence is a virus, viral vector, plasmid, antisense oligonucleotide, or ribozyme.

### Claim 14 (depends on 12)

The method of claim 12, wherein said nucleic acid sequence is a viral vector.

### Claim 15 (depends on 18)

The method of claim 18, wherein the therapeutic agent is a cytokine.

### Claim 16 (depends on 18)

The method of claim 18, wherein the therapeutic agent is a radiosensitizing gene.

### Claim 17 (depends on 16)

The method of claim 16, wherein the hollow container further contains a radioisotope.

### Claim 18

A method for delivering a therapeutic agent to a targeted site in a living subject by interstitial drug delivery, comprising the following steps:
i) producing a hollow container sized and adapted for insertion into a tissue or organ in vivo, and having encapsulated in the hollow interior thereof at least one therapeutic agent capable of diffusing out of said container through one or more holes therein;
ii) freezing said container and the therapeutic agent therein to a temperature of about −70° C.
iii) maintaining said container and the therapeutic agent therein in a frozen state from said freezing until insertion into a living subject;
iv) inserting one or more of said therapeutic agent containing containers to within about 1 millimeter of a targeted site within tissue or an organ in said living subject; and
v) permitting the therapeutic agent to diffuse from said container at said targeted site.

### Claim 19 (depends on 18)

The method of claim 18, wherein said therapeutic agent-containing container is housed in a storage cartridge which is capable of withstanding a temperature of about −70° C.

### Claim 20 (depends on 19)

The method of claim 19, wherein said storage cartridge comprises one or more compartments, each of said one or more compartments being constructed and arranged to house one or more of said containers.
